TY - JOUR
T1 - Isoniazid-loaded orodispersible strips
T2 - Methodical design, optimization and in vitro-in silico characterization
AU - Adeleke, Oluwatoyin Ayotomilola
AU - Tsai, Pei Chin
AU - Karry, Krizia M.
AU - Monama, Nkwe O.
AU - Michniak-Kohn, Bozena B.
N1 - Funding Information:
The authors would like to acknowledge funding provided by the US Department of State Bureau of Educational and Cultural Affairs, William J. Fulbright Program (Grant Number-68140541), the Department of Science and Technology and National Research Foundation, South Africa (Grant Number-85110) and the UNESCO-L’Oréal FWIS Program. We are thankful to the New Jersey Center for Biomaterials, Rutgers - The State University of New Jersey, USA and the Center for High Performance Computing, Council for Scientific and Industrial Research, South Africa for providing complementary funds. OA thanks Prof. Rose Hayeshi and Dr. Happy Sithole at the Council for Scientific and Industrial Research for their valuable dialogues and support.
Publisher Copyright:
© 2018 Elsevier B.V.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/8/25
Y1 - 2018/8/25
N2 - Drug treatment remains the most effective global approach to managing and preventing tuberculosis. This work focuses on formulating and evaluating an optimized polyvinyl alcohol-polyethylene glycol based orodispersible strip containing isoniazid, a first-line anti-tubercular agent. A solvent casting method guided through a Taguchi experimental design was employed in the fabrication, optimization and characterization of the orodispersible strip. The optimized strip was physically amalgamated with a monolayer, uniformly distributed surface geometry. It was 159.2 ± 3.0 µm thick, weighed 36.9 ± 0.3 mg, had an isoniazid load of 99.5 ± 0.8%w/w, disintegration and dissolution times of 17.6 ± 0.9 s and 5.5 ± 0.1 min respectively. In vitro crystallinity, thermal measurements and in silico thermodynamic predictions confirmed the strip's intrinsic miscibility, thermodynamic stability and amorphous nature. A Korsmeyer-Peppas (r = 0.99; n > 1 = 1.07) fitted kinetics typified by an initial burst release of 49.4 ± 1.9% at 4 min and a total of 99.8 ± 3.3% at 30 min was noted. Ex vivo isoniazid permeation through porcine buccal mucosa was bi-phasic and characterized by a 50.4 ± 3.8% surge and 95.6 ± 2.9% at 5 and 120 min respectively. The strip was physicomechanically robust, environmentally stable and non-cytotoxic.
AB - Drug treatment remains the most effective global approach to managing and preventing tuberculosis. This work focuses on formulating and evaluating an optimized polyvinyl alcohol-polyethylene glycol based orodispersible strip containing isoniazid, a first-line anti-tubercular agent. A solvent casting method guided through a Taguchi experimental design was employed in the fabrication, optimization and characterization of the orodispersible strip. The optimized strip was physically amalgamated with a monolayer, uniformly distributed surface geometry. It was 159.2 ± 3.0 µm thick, weighed 36.9 ± 0.3 mg, had an isoniazid load of 99.5 ± 0.8%w/w, disintegration and dissolution times of 17.6 ± 0.9 s and 5.5 ± 0.1 min respectively. In vitro crystallinity, thermal measurements and in silico thermodynamic predictions confirmed the strip's intrinsic miscibility, thermodynamic stability and amorphous nature. A Korsmeyer-Peppas (r = 0.99; n > 1 = 1.07) fitted kinetics typified by an initial burst release of 49.4 ± 1.9% at 4 min and a total of 99.8 ± 3.3% at 30 min was noted. Ex vivo isoniazid permeation through porcine buccal mucosa was bi-phasic and characterized by a 50.4 ± 3.8% surge and 95.6 ± 2.9% at 5 and 120 min respectively. The strip was physicomechanically robust, environmentally stable and non-cytotoxic.
KW - Buccal absorption
KW - Experimental design
KW - Isoniazid
KW - Monolayer film
KW - Orodispersible strip
KW - Tuberculosis
UR - http://www.scopus.com/inward/record.url?scp=85048179256&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2018.06.004
DO - 10.1016/j.ijpharm.2018.06.004
M3 - Article
C2 - 29879506
SN - 0378-5173
VL - 547
SP - 347
EP - 359
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1-2
ER -